Search

Search Constraints

You searched for: Author/Creator Raposeiras-Roubin, Sergio

Search Results

1. "Assessment of effectiveness and security in high pressure postdilatation of bioresorbable vascular scaffolds during percutaneous coronary intervention. Study in a contemporary, non-selected cohort of Spanish patients". (15th September 2016)

2. Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry. Issue 2 (5th October 2021)

3. Comparison between CHA2DS2-VASc and the new R2CHADS2 and ATRIA scores at predicting thromboembolic event in non-anticoagulated and anticoagulated patients with non-valvular atrial fibrillation. Issue 1 (December 2015)

4. Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry. (15th December 2018)

5. Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry. (29th August 2020)

6. Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry. (May 2020)

7. Long-term outcome prediction of CHA2DS2VASc and HATCH scores in a cohort of patients with typical atrial flutter. (15th November 2015)

8. Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets. Issue 10270 (16th January 2021)

9. Net clinical benefit of different strategies of dual antiplatelet therapy in elderly patients: Data from the praise registry. (15th April 2022)

10. Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMI. Issue 6 (1st September 2019)